CTI BioPharma Cash Flow Statement

Financials in millions NGN. Fiscal year is January - December.

Millions NGN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	1,779	5,576	232.9	-704.55	-615.04	Upgrade
Depreciation & Amortization	167.69	77.01	26.92	82.15	85.23	Upgrade
Other Amortization	-	1.51	0.02	3.81	1.45	Upgrade
Gain (Loss) on Sale of Assets	-	1.18	1,545	-	2.62	Upgrade
Gain (Loss) on Sale of Investments	-	-558.95	112.54	8.05	-96.05	Upgrade
Change in Accounts Receivable	-	-8.64	-	-23.78	12.02	Upgrade
Reinsurance Recoverable	-	-44.62	-18.57	31.63	25.54	Upgrade
Change in Accounts Payable	-	52.22	-1.61	31.55	10.7	Upgrade
Change in Insurance Reserves / Liabilities	-	743.33	81.32	137.51	56.96	Upgrade
Change in Other Net Operating Assets	-	2,069	-357.88	76.06	166.68	Upgrade
Other Operating Activities	-2,634	-4,340	-252.56	517.25	475.36	Upgrade
Operating Cash Flow	-687.4	3,583	-601.2	-49.98	4.05	Upgrade
Capital Expenditures	-396.58	-675.1	-189.52	-24.24	-42.18	Upgrade
Sale of Property, Plant & Equipment	17.98	1.18	0.26	-	2.68	Upgrade
Purchase / Sale of Intangible Assets	-194.7	-36.72	-2.37	-3.19	-1.68	Upgrade
Investment in Securities	873.27	-3,600	-	-	-	Upgrade
Other Investing Activities	437.4	173.33	24.29	53.79	66.87	Upgrade
Investing Cash Flow	524.05	-4,150	732.67	26.37	25.69	Upgrade
Total Debt Repaid	-30.49	-37.54	-	-12	-12	Upgrade
Net Debt Issued (Repaid)	-30.49	-37.54	-	-12	-12	Upgrade
Issuance of Common Stock	-	-	5,000	-	-	Upgrade
Other Financing Activities	-3,012	-258.98	-0.89	-8.71	-9.61	Upgrade
Financing Cash Flow	-3,043	-296.51	4,999	-20.71	-21.61	Upgrade
Foreign Exchange Rate Adjustments	11.89	9.76	2.88	3.55	3.13	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-	0	0	Upgrade
Net Cash Flow	-3,194	-853.48	5,133	-40.77	11.27	Upgrade
Free Cash Flow	-1,084	2,908	-790.72	-74.21	-38.12	Upgrade
Free Cash Flow Margin	-16.49%	77.69%	-69.04%	-4.55%	-2.60%	Upgrade
Free Cash Flow Per Share	-0.84	2.27	-0.62	-0.06	-0.03	Upgrade
Cash Interest Paid	12.38	8.68	-	8.71	8.71	Upgrade
Cash Income Tax Paid	153.26	105.82	212.59	4.3	1.48	Upgrade
Levered Free Cash Flow	2,411	1,998	-1,593	75.79	-2.23	Upgrade
Unlevered Free Cash Flow	2,419	-175.05	-1,587	81.24	3.22	Upgrade
Change in Net Working Capital	-1,494	446.71	1,654	-228.48	-86.9	Upgrade

Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.